Morphogenesis, Inc

Website Links

Description

Dr. Hardwick has 17 years experience in biomedical process and product development. Most recently he served as Director, Cell Processing at Xcyte Therapies, Inc., a Seattle-based biotechnology company focused on cellular therapies. In this capacity, he directed the development and documentation of a closed-system, large-scale process for preparing, culturing, harvesting and shipping of patient T-cells for use in adoptive immunotherapy protocols. From 1983 to 1998 Dr.

April 1, 2012, Morphogenesis and Veterinary Oncology Services moved their corporate and R&D operations to 4613 N Clark Avenue, Tampa, FL, a stand-alone building near the Tampa International Airport.

Our company is focused on the use of cells as diagnostic and therapeutic agents because cells fulfill all the qualifications and characteristics needed to solve the unsolvable.

Mr. Scanlan was also president and part owner of MP Total Care, a company specializing in respiratory medication. Within two years, he increased revenue of this five year old company from five million dollars a year to two million dollars a month, making it the largest independent distributor of its kind in the United States.

We salute you, Sam, for your vision, your tenacity, your principles, your dedication, your passion and your compassion. We are honored to have known you and to have had you as a mentor, advisor, colleague and friend. Thank you so much for all that you have given to your colleagues, your students, your family and your patients. Your contributions to clinical medicine and society cannot be measured by the many pages you have written or even the children you have saved, for you have touched the lives of so many and have inspired that many more .

Products & services

Similar companies nearby